Second Sight Medical Products, Inc.
The recognized global leader in neuromodulation devices to treat blindness, the company leverages its 20 years of technology innovation to develop devices to treat the broadest population of sight-impaired individuals. Inspired by personal connections with a retinitis pigmentosa diagnosis, Second Sight has researched, designed and created the world’s ?rst FDA and CE Mark approved device for providing artificial vision in people with late-stage RP.
The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes.
Argus® II Retinal Prosthesis System is intended to provide useful vision to blind individuals severely impacted by RP. It combines a miniature eye implant with a patient-worn camera and processor to transform how you experience the world.
Implanting the Argus II is a well -established surgery, typically taking only a few hours. The procedure is performed by an experienced retinal surgeon, with Second Sight technicians available for your support. Once implanted, the Argus II implant sits in and around the back of the eye and is not visible to others. It is accompanied by external accessories that include glasses with a built in camera and a small portable processing unit that together capture and process video signals to be sent to the implant. Once the Argus II has been implanted, you will return to the clinic after approximately 4 weeks of healing to have your Argus II activated and programed to your specific needs.